Marker Therapeutics, Inc. (MRKR) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 1.23M | 861.18K | 349.1K | 2.25M | 1.93M | 1.17M | 1.24M | 1.06M | 257.61K | 762.66K | 1.23M | 759.14K | 999.57K | 790.51K | 964.32K | 1.24M | 0 | 0 |
| Revenue Growth % | -100% | -100% | -35.98% | -26.35% | -71.94% | 113.13% | 647.65% | 53.31% | 0.79% | 39.17% | -74.23% | -3.52% | 28% | -38.86% | - | - | - | - | - | -100% |
| Cost of Goods Sold | 0 | 0 | 0 | 4.18M | 3.14M | 5.09M | 3.47M | 2.34M | 2.58M | 2.62M | 2.04M | 2.38M | 3.38M | 2.18M | 3.59M | 2.92M | 834.22K | 820.18K | 805.25K | 782.83K |
| COGS % of Revenue | - | - | - | 485.04% | 898.14% | 225.88% | 180.22% | 199.74% | 206.98% | 247.73% | 793.84% | 311.8% | 273.55% | 287.47% | 359.34% | 369.87% | 86.51% | 66.05% | - | - |
| Gross Profit | 0 | 0 | 1.23M | -3.32M | -2.79M | -2.83M | -1.54M | -1.17M | -1.33M | -1.56M | -1.79M | -1.62M | -2.14M | -1.42M | -2.59M | -2.13M | 130.1K | 421.52K | -805.25K | -782.83K |
| Gross Margin % | - | - | 100% | -385.04% | -798.14% | -125.88% | -80.22% | -99.74% | -106.98% | -147.73% | -693.84% | -211.8% | -173.55% | -187.47% | -259.34% | -269.87% | 13.49% | 33.95% | - | - |
| Gross Profit Growth % | 100% | 100% | 179.8% | -184.33% | -109.35% | -81.6% | 13.56% | 27.8% | 37.87% | -9.67% | 31.05% | 24.28% | -1746.52% | -437.62% | -221.93% | -172.52% | 117.25% | 190.57% | -107.19% | 79.45% |
| Operating Expenses | 4.07M | 1.88M | 3.37M | 945.16K | 1.82M | 1.03M | 854.68K | 1.14M | 1.22M | 1.38M | 1.41M | 2.52M | 2.17M | 1.62M | 3.23M | 3.14M | 9.92M | 10.19M | 9.22M | 10.13M |
| OpEx % of Revenue | - | - | 273.3% | 109.75% | 522.01% | 45.61% | 44.38% | 97.66% | 97.91% | 130.33% | 548.39% | 330.26% | 175.59% | 212.81% | 323.55% | 396.6% | 1029.2% | 820.31% | - | - |
| Selling, General & Admin | 1.23M | 846.61K | 1.02M | 945.16K | 1.37M | 1.03M | 854.68K | 1.14M | 1.22M | 1.38M | 1.41M | 2.52M | 2.17M | 1.62M | 3.23M | 3.14M | 2.9M | 2.17M | 2.43M | 2.78M |
| SG&A % of Revenue | - | - | 83.04% | 109.75% | 392.21% | 45.61% | 44.38% | 97.66% | 97.91% | 130.33% | 548.38% | 330.26% | 175.59% | 212.81% | 323.55% | 396.6% | 300.6% | 174.63% | - | - |
| Research & Development | 2.84M | 2.14M | 2.35M | 4.18M | 3.14M | 5.09M | 3.47M | 2.34M | 2.58M | 2.62M | 2.04M | 2.38M | 3.38M | 2.18M | 3.59M | 2.92M | 7.03M | 8.02M | 6.78M | 7.35M |
| R&D % of Revenue | - | - | 190.26% | 485.04% | 898.14% | 225.88% | 180.22% | 199.74% | 206.98% | 247.73% | 793.84% | 311.8% | 273.55% | 287.47% | 359.34% | 369.87% | 728.6% | 645.68% | - | - |
| Other Operating Expenses | 0 | -1000K | 0 | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | -1000K | 0 | 0 | 0 | 0 |
| Operating Income | -4.07M | -1.88M | -2.14M | -4.26M | -4.61M | -3.86M | -2.4M | -2.31M | -2.55M | -2.94M | -3.2M | -4.13M | -4.31M | -3.04M | -5.83M | -5.27M | -9.79M | -9.76M | -10.02M | -10.91M |
| Operating Margin % | - | - | -173.3% | -494.79% | -1320.14% | -171.48% | -124.61% | -197.4% | -204.89% | -278.06% | -1242.22% | -542.06% | -349.13% | -400.28% | -582.9% | -666.47% | -1015.71% | -786.36% | - | - |
| Operating Income Growth % | 11.63% | 51.21% | 10.97% | -84.61% | -80.8% | -31.44% | 25% | 44.17% | 40.85% | 3.32% | 45.08% | 21.53% | 56% | 68.88% | 41.87% | 51.71% | -11.54% | -14.76% | -35.89% | -71.59% |
| EBITDA | -4.07M | -1.88M | -2.14M | -4.26M | -453.13K | -3.86M | -2.4M | 0 | 0 | -2.24M | -2.5M | -3.32M | -3.49M | -2.23M | -5.01M | -4.69M | -8.96M | -8.94M | -9.22M | -10.13M |
| EBITDA Margin % | - | - | -173.3% | -494.79% | -129.8% | -171.48% | -124.61% | - | - | -212.06% | -971.55% | -434.77% | -282.85% | -293.17% | -500.87% | -593.13% | -929.2% | -720.31% | - | - |
| EBITDA Growth % | -798.75% | 51.21% | 10.97% | - | - | -72.35% | 4.11% | 100% | 100% | -0.67% | 50.01% | 29.28% | 61.04% | 75.12% | 45.69% | 53.7% | -11.64% | -11.2% | -31.93% | -61.55% |
| D&A (Non-Cash Add-back) | 0 | 0 | -4 | 3 | 4.16M | -3 | 0 | 2.31M | 2.55M | 697.28K | 697.28K | 818.22K | 818.22K | 813.11K | 819.88K | 579.78K | 834.22K | 820.18K | 805.25K | 782.83K |
| EBIT | -4.07M | -1.88M | -2M | -4.26M | -4.16M | -3.86M | -2.4M | -2.31M | -2.55M | -2.94M | -3.2M | -4.13M | -4.31M | -3.04M | -5.83M | -5.27M | -9.91M | -9.76M | -12.43M | -10.91M |
| Net Interest Income | 132.89K | 165.63K | 138.06K | 128.03K | 162.49K | 73.75K | 91.68K | 115.39K | 156.19K | 201.34K | 218.09K | 35.08K | 84.65K | 109.41K | 99.75K | 35.79K | 3.12K | 969 | 791 | 2.4K |
| Interest Income | 132.89K | 165.63K | 138.06K | 128.03K | 162.49K | 73.75K | 91.68K | 115.39K | 156.19K | 201.34K | 218.09K | 35.08K | 84.65K | 109.41K | 99.75K | 35.79K | 3.12K | 969 | 791 | 2.4K |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Income/Expense | 893.26K | 165.63K | 138.06K | 245.47K | 162.49K | 73.75K | 91.68K | 115.39K | 156.19K | 201.34K | 218.09K | 35.08K | 84.65K | -4.68K | 99.75K | 35.79K | -115.76K | 969 | -2.41M | 2.4K |
| Pretax Income | -3.18M | -1.72M | -2M | -4.02M | -4.45M | -3.79M | -2.31M | -2.19M | -2.39M | -2.74M | -2.98M | -4.1M | -4.22M | -3.04M | -5.73M | -5.23M | -9.91M | -9.76M | -12.43M | -10.91M |
| Pretax Margin % | - | - | -162.11% | -466.28% | -1273.6% | -168.21% | -119.83% | -187.53% | -192.34% | -259% | -1157.57% | -537.46% | -342.28% | -400.89% | -572.92% | -661.95% | -1027.72% | -786.28% | - | - |
| Income Tax | 0 | -15.16K | 0 | 0 | 0 | 49.95K | 0 | 0 | 0 | 3.67K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0.88% | 0% | 0% | 0% | -1.32% | 0% | 0% | 0% | -0.13% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -3.18M | -1.7M | -2M | -4.02M | -4.45M | -3.84M | -2.31M | -2.19M | -2.39M | -2.8M | -2.98M | 2.52M | -4.97M | -3.86M | -6.92M | -9.24M | -9.91M | -9.76M | -12.43M | -10.91M |
| Net Margin % | - | - | -162.11% | -466.28% | -1273.6% | -170.43% | -119.83% | -187.53% | -192.34% | -265.31% | -1157.57% | 329.87% | -402.45% | -508% | -692.26% | -1169.4% | -1027.72% | -786.28% | - | - |
| Net Income Growth % | 28.49% | 55.62% | 13.4% | -83.14% | -85.81% | -36.91% | 22.6% | -187.16% | 51.83% | 27.31% | 56.91% | 127.21% | 49.88% | 60.5% | 44.33% | 15.24% | -12.88% | -14.77% | -68.61% | -71.99% |
| Net Income (Continuing) | -3.18M | -1.7M | -2M | -4.02M | -4.45M | -3.84M | -2.31M | -2.19M | -2.39M | -2.74M | -2.98M | -4.1M | -4.22M | -3.04M | -5.73M | -5.23M | -9.91M | -9.76M | -12.43M | -10.91M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -62.94K | 0 | 1000K | -742.75K | -813.06K | -1000K | -1000K | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.16 | -0.10 | -0.12 | -0.29 | -0.40 | -0.42 | -0.26 | -0.25 | -0.27 | -0.31 | -0.34 | 0.29 | -0.57 | -0.48 | -0.83 | -1.11 | -1.19 | -1.17 | -1.50 | -1.30 |
| EPS Growth % | 60% | 76.19% | 53.85% | -16% | -48.15% | -35.48% | 23.53% | -186.21% | 52.63% | 35.42% | 59.04% | 126.13% | 52.1% | 58.97% | 44.67% | 14.62% | 25.62% | 33.14% | 6.25% | 7.14% |
| EPS (Basic) | -0.16 | -0.10 | -0.12 | -0.29 | -0.40 | -0.42 | -0.26 | -0.25 | -0.27 | -0.31 | -0.34 | 0.29 | -0.57 | -0.48 | -0.83 | -1.11 | -1.19 | -1.19 | -1.50 | -1.30 |
| Diluted Shares Outstanding | 19.31M | 15.31M | 16.76M | 13.96M | 11.11M | 9.1M | 8.92M | 8.92M | 8.9M | 8.9M | 8.83M | 8.8M | 8.72M | 8.4M | 8.36M | 8.36M | 8.31M | 8.31M | 8.31M | 8.3M |
| Basic Shares Outstanding | 19.31M | 15.31M | 16.76M | 13.96M | 11.11M | 9.1M | 8.92M | 8.92M | 8.9M | 8.9M | 8.83M | 8.8M | 8.72M | 8.4M | 8.36M | 8.36M | 8.31M | 8.17M | 8.29M | 8.3M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |